๐ฐ Ilan Danieli News
Page 2 - Ilan Danieli News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ilan Danieli. Real-time updates on events, politics, business and more.
April 9, 2023
Operator: Welcome to the Precipio shareholder 2022 Fourth Quarter and Year-End Shareholder Update Conference Call. All participants will be in listen-only mode.
February 14, 2023
HemeScreen® Technology and Product Line singled out from thousands of products distributed by Fisher Healthcare at recent National Sales Meeting...
November 7, 2022
Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreenโข MPN Assay...
June 14, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 24, 2022
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.
March 22, 2022
Precipio announced that chief financial officer Carl Iberger resigned and Matt Gage was named as the interim replacement.
March 21, 2022
21.03.2022 - NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl Iberger, Precipioโs CFO for the past five years, is resigning as the Chief Financial Officer ... Seite 1
May 19, 2021
3 Penny Stocks To Watch After Crypto News Crashes Digital Asset Prices Penny stocks are well-known for their high-risk nature. But lately, things like bitcoin price and cryptocurrency news have gotten wrapped into the fold. In particular, when cryptos like Dogecoin and Ethereum began jumping, traders placed a broader focus on riskier assets. Where we first saw Reddit act as a catalyst for things like penny stocks, these cheap stocks have now become one piece of a much larger asset class. Now, ...
May 10, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time Precipio, Inc.May 10, 2021 GMT NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc.(NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML) HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leu...
March 3, 2021
(NASDAQ:PRPO) announces that Mr. Ron Andrews has joined the companys Board of Directors. As the company continues to build its products division around commercializing the technologies it has developed (such as HemeScreen and IV-cell), having additional resources and experienced industry veterans to support managements goals is key to its success and ongoing growth. Mr. Andrews brings a wealth of experience in the diagnostics world, and specifically in the areas of product development & commerc...